Varenicline Dosing for Smoking Cessation
The standard varenicline dosing regimen is 0.5 mg once daily for days 1-3, then 0.5 mg twice daily for days 4-7, followed by 1 mg twice daily from week 2 through week 12, with treatment initiated 1-2 weeks before the target quit date 1, 2.
Standard Dosing Schedule
The FDA-approved titration schedule minimizes adverse effects while achieving therapeutic efficacy:
- Days 1-3: 0.5 mg orally once daily
- Days 4-7: 0.5 mg orally twice daily
- Week 2 through 12: 1 mg orally twice daily (target dose)
Take varenicline after eating with a full glass of water 2. Begin dosing 1-2 weeks before the planned quit date, though patients may alternatively start varenicline and quit smoking between days 8-35 of treatment 2.
Treatment Duration
A minimum of 12 weeks is recommended for the initial quit attempt 1. For patients who successfully quit after 12 weeks, an additional 12-week course (total 24 weeks) is recommended to increase long-term abstinence rates 1, 2. Therapy may be extended to 6 months to 1 year to promote continued cessation 1.
For patients using a gradual quit approach (reducing smoking by 50% every 4 weeks), continue treatment for 24 weeks total 2.
Dose Adjustments for Renal Impairment
Renal function is the most clinically important factor affecting varenicline exposure 3:
- Mild to moderate renal impairment: No dose adjustment necessary 2
- Severe renal impairment (CrCl <30 mL/min): Start with 0.5 mg once daily, may titrate to maximum 0.5 mg twice daily 2
- End-stage renal disease on hemodialysis: Maximum dose 0.5 mg once daily if tolerated 2
No dose adjustment is needed for hepatic impairment 2.
Use in Pregnancy
Varenicline is not recommended during pregnancy due to insufficient safety data 4, 5, 6. Available evidence shows:
- Very limited data on pregnancy outcomes with varenicline use 5
- FDA labeling states available studies cannot definitively establish or exclude varenicline-associated risk during pregnancy 7
- Most use occurs in the first trimester when organogenesis is critical 4
- Professional guidelines recommend against varenicline use in pregnancy 6
For pregnant smokers, behavioral interventions are first-line treatment 7, 5. Nicotine replacement therapy may be considered if behavioral interventions fail, though data on efficacy during pregnancy are mixed 5, 6.
Dose Modifications for Tolerability
Consider temporary or permanent dose reduction if patients cannot tolerate adverse effects 2. Flexible dosing (0.5 mg/day to 1 mg twice daily) may eliminate dose-dependent adverse effects while retaining efficacy 8, 9. Most patients in flexible dosing studies took approximately 1.3 mg/day and achieved abstinence rates >40% at 12 weeks 8.
Important Safety Considerations
- Nausea is the most common adverse effect and may require management, especially in cancer patients receiving chemotherapy 1
- Contraindicated in patients with brain metastases due to seizure risk 1
- Monitor for neuropsychiatric symptoms (depression, suicidal ideation, behavioral changes), though recent large trials found no significant increase in neuropsychiatric adverse events compared to placebo 1
- No clinically significant drug interactions with warfarin, digoxin, bupropion, or nicotine replacement therapy 3, 10
- No dose adjustment needed based on age, sex, or race after accounting for renal function 3
Clinical Pearls
Follow-up within 2 weeks of starting pharmacotherapy is recommended 1. Dose adjustments may be considered as clinically indicated 1. If patients relapse after initial treatment, they should be encouraged to make another attempt once contributing factors are addressed 2.